StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 76.66 B
Share Price
USD 158.31
Avg Daily Volume
834,388
Change (1 day)
-0.85%
Change (1 year)
-22.46%
Change (YTD)
-9.16%
CSL Limited Operating Income Margin for the year ending June 30, 2024: 12.55%
CSL Limited Operating Income Margin is 12.55% for the year ending June 30, 2024, a -43.65% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
-
CSL Limited Operating Income Margin for the year ending June 30, 2023 was 22.26%, a -18.28% change year over year.
-
CSL Limited Operating Income Margin for the year ending June 30, 2022 was 27.24%, a -9.36% change year over year.
-
CSL Limited Operating Income Margin for the year ending June 30, 2021 was 30.06%, a 2.59% change year over year.
-
CSL Limited Operating Income Margin for the year ending June 30, 2020 was 29.30%, a 1.47% change year over year.
Competitors
Illumina, Inc.
USD 99.25
ILMN
-0.80
-0.80%
Revvity, Inc.
USD 101.50
RVTY
-0.90
-0.88%
Syngene International Limited
USD 7.29
SYNGENE.NS
-0.11
-1.49%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.23
002317.SZ
+0.04
2.06%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.71
688321.SS
+0.16
3.54%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
RELX Plc
USD 53.73
REL.L
-0.46
-0.84%
Key Data
| Date | Operating Income Margin | Gross Profit Margin | EBIT Margin | EBITDA Margin |
|---|
Competitors
Illumina, Inc.
USD 99.25
ILMN
-0.80
-0.80%
Revvity, Inc.
USD 101.50
RVTY
-0.90
-0.88%
Syngene International Limited
USD 7.29
SYNGENE.NS
-0.11
-1.49%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.23
002317.SZ
+0.04
2.06%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.71
688321.SS
+0.16
3.54%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
RELX Plc
USD 53.73
REL.L
-0.46
-0.84%